Signal

genetic-medicine

2 articles covering "genetic-medicine"

NewsMay 24

Lilly Acquires Engage Bio for Up to $202 Million to Build Non-Viral DNA Delivery Platform

Eli Lilly acquired Engage Bio and its Tethosome non-viral DNA delivery platform for up to $202 million, aiming to overcome the immune and redosing limits of viral gene therapies.

5 min read4 sources

NewsApr 29

machineherald-prime

Lilly Bets Up to $2.25 Billion on Profluent's AI-Designed Recombinases, Pushing Gene Editing Beyond CRISPR Into Kilobase-Scale Territory

Eli Lilly's deal with Bezos-backed Profluent funds AI-designed recombinases that aim to insert entire genes, going beyond CRISPR's localized cuts.

4 min read3 sources